Results 11 to 20 of about 102,405 (251)

Cost-effectiveness of mechanical thromboprophylaxis for cesarean deliveries in Brazil.

PLoS ONE, 2023
ObjectiveTo evaluate the cost-effectiveness of using mechanical thromboprophylaxis for patients undergoing a cesarean delivery in Brazil.MethodsA decision-analytic model built in TreeAge software was used to compare the cost and effectiveness of ...
Alex Veloz, Ubong Silas, Rhodri Saunders, Jody Grisamore, André Luiz Malavasi   +4 more
doaj   +3 more sources

The anti-cancer properties of heparin and its derivatives: a review and prospect

Cell Adhesion & Migration, 2020
Heparin, including unfractionated heparin (UFH), low-molecular-weight heparin (LMWH) and heparin derivatives, are commonly used in venous thromboembolism treatment and reportedly have beneficial effects on cancer survival.
Sai-Nan Ma, Zhi-Xiang Mao, Yang Wu, Ming-Xing Liang, Dan-Dan Wang, Xiu Chen, Ping-an Chang, Wei Zhang, Jin-Hai Tang   +8 more
doaj   +1 more source

Low-Molecular-Weight Heparin–Induced Skin Necrosis Without Thrombocytopenia

Annals of Internal Medicine: Clinical Cases, 2023
Heparin-induced skin necrosis is an immune-based entity that appears secondary to exposure to unfractionated heparin or low-molecular-weight heparin, consisting of the appearance of erythematous lesions that can progress to necrosis at the point of ...
Ana Quiles-Recuenco, Selene Falcon-Vega, Nuria Selles-Galiana, Maria Andreo-Galera, Azucena Sempere-Mira   +4 more
doaj   +1 more source

Role of low molecular weight of heparin in preventing severe preeclampsia [PDF]

Al-Azhar International Medical Journal, 2022
Background: This condition is known as preeclampsia, which is characterized by new-onset hypertension after twenty weeks of gestation with indications of organ damage; the potential maternal and neonatal consequences of preeclampsia are considerable ...
Al-Refaai Marai, Abdallah Ahmed, Mostafa Attia   +2 more
doaj   +1 more source

An Ovarian Cancer Patient Presenting Heparin - Induced Thrombocytopenia after use of Low - Molecular - Weight Heparin: A Case Report of Rare Condition

Gynecology Obstetrics & Reproductive Medicine, 2019
Heparin-induced thrombocytopenia is a rare and life-threatening condition of exposure to heparin. A case of heparin-induced thrombocytopenia due to the low molecular weight heparin was presented.
Yasin Durmuş, Yalin Ay Karyal, Cigdem Kilic, Caner Cakir, Dilek Yuksel, Berna Seyhan, Gokhan Boyraz, Gunsu Kimyon Comert, Taner Turan   +8 more
doaj   +1 more source

Preventive effect of low molecular weight heparin on thrombosis formation in microvascular anastomosis

Acta Orthopaedica et Traumatologica Turcica, 2021
Antithrombotic effect of the low molecular weight heparin (L.M.W.H) in microvascular anastomosis was investigated with femoral arteries of the rats. Femoral arteries of 28 rats were cut and anastomosed end to end with microsurgical technique.
Oguz Ozdemir, Erhan Coskunol, Zeki Ozcan, Gulcin Basdemir   +3 more
doaj  

Thromboprophylaxis in obstetrics: who, when and how [PDF]

Гинекология, 2014
The article highlights the current issues of the use of anticoagulants (unfractionated and low molecular weight heparin) for the prevention of venous thromboembolic complications in obstetric practice.
A V Kulikov, E M Schiffman, I B Zabolotskikh, S V Sinkov, S R Belomestnov   +4 more
doaj  

Heparin-Induced Hyperkalemia Assessment Utilizing the Naranjo Adverse Drug Reaction Probability Scale: A 40-Year Systematic Review

Pharmacy
Background: Adverse drug reactions have been reported as leading causes of morbidity and mortality. Unfractionated heparin- and low-molecular-weight heparin-induced hyperkalemia are side effects that have been reported in approximately 7 to 8% of heparin-
Divita Singh, Omnia A. E. A. Mesalhy, Michael J. Cawley   +2 more
doaj   +1 more source

Compression stockings in addition to low-molecular-weight heparin to prevent venous thromboembolism in surgical inpatients requiring pharmacoprophylaxis: the GAPS non-inferiority RCT

Health Technology Assessment, 2020
Background: Patients admitted to hospital for surgery are at an increased risk of venous thromboembolism. Pharmaco-thromboprophylaxis and mechanical prophylaxis (usually graduated compression stockings or intermittent pneumatic compression) have been ...
Joseph Shalhoub, Rebecca Lawton, Jemma Hudson, Christopher Baker, Andrew Bradbury, Karen Dhillon, Tamara Everington, Manjit S Gohel, Zaed Hamady, Beverly J Hunt, Gerard Stansby, David Warwick, John Norrie, Alun H Davies   +13 more
doaj   +1 more source

ANTITHROMBOTIC THERAPY IN CANCER PATIENTS

Акушерство, гинекология и репродукция, 2016
The article describes the main anticoagulant drugs used in cancer patients, taking into consideration pathogenetic aspects of hypercoagulation status in cancer patients: oral anticoagulants, heparin drugs, selective inhibitors of Xa factor.
A. V. Vorobev, A. M. Chabrov, A. A. Savchenko, A. D. Makatsariya   +3 more
doaj   +1 more source